发明名称 Substituted quinoxalines as FGFR kinase inhibitors
摘要 The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.;
申请公布号 US9303029(B2) 申请公布日期 2016.04.05
申请号 US201214354636 申请日期 2012.10.26
申请人 ASTEX THERAPEUTICS LTD 发明人 Woodhead Steven John;Murray Christopher William;Berdini Valerio;Saxty Gordon;Besong Gilbert Ebai;Meerpoel Lieven;Querolle Olivier Alexis Georges;Poncelet Virginie Sophie
分类号 A61K31/498;C07D241/42;C07D471/04;C07D403/12;C07D401/14;C07D413/14;C07D401/04;C07D401/06;C07D401/12;C07D403/04;C07D403/06;C07D407/04;C07D407/14;C07D413/04;C07D417/04;C07D241/44;C07D417/12;A61K31/4985;A61K31/506;A61K45/06;C07D405/04;C07D405/14 主分类号 A61K31/498
代理机构 Heslin Rothenberg Farley & Mesiti P.C. 代理人 Heslin Rothenberg Farley & Mesiti P.C.
主权项 1. A compound selected from the group consisting of a compound of formula (I): a tautomeric form, and stereochemically isomeric form thereof, wherein W is —N(R3)— or —C(R3aR3b)—; each R2 is independently selected from hydroxyl, halogen, cyano, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, C1-4alkoxy, hydroxyC1-4alkyl, hydroxyC1-4alkoxy, haloC1-4alkyl, haloC1-4alkoxy, hydroxyhaloC1-4alkyl, hydroxyhaloC1-4alkoxy, C1-4alkoxyC1-4alkyl, haloC1-4alkoxyC1-4alkyl, C1-4alkoxyC1-4alkyl wherein each C1-4alkyl may optionally be substituted with one or two hydroxyl groups, hydroxyhaloC1-4alkoxyC1-4alkyl, R13, C1-4alkyl substituted with R13, C1-4alkyl substituted with —C(═O)—R13, C1-4alkoxy substituted with R13, C1-4alkoxy substituted with —C(═O)—R13, —C(═O)—R13, C1-4alkyl substituted with —NR7R8, C1-4alkyl substituted with —C(═O)—NR7R8, C1-4alkoxy substituted with —NR7R8, C1-4alkoxy substituted with —C(═O)—NR7R8, —NR7R8 and —C(═O)—NR7R8; or when two R2 groups are attached to adjacent carbon atoms they may be taken together to form a radical of formula: —O—(C(R17)2)p—O—;—X—CH═CH—; or—X—CH═N—;wherein R17 represents hydrogen or fluorine, p represents 1 or 2 and X represents O or S; Y represents —CR18═N—OR19 or -E-D; E represents a bond, —(CR22R23)n—, C2-4alkenediyl optionally substituted with R22, C2-4alkynediyl optionally substituted with R22, —CO—(CR22R23)s—, —(CR22R23)s—CO—, —NR22—(CR22R23)s—, —(CR22R23)s—NR22—, —O—(CR22R23)s—, —(CR22R23)s—O—, —S(O)m—(CR22R23)s—, —(CR22R23)s—S(O)m—, —(CR22R23)s—CO—NR22—(CR22R23)s— or —(CR22R23)s—NR22—CO—(CR22R23)s—; D represents a 3 to 12 ring membered monocyclic or bicyclic carbocyclyl or a 3 to 12 ring membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O and S, wherein said carbocyclyl and heterocyclyl may each be optionally substituted by one or more R1 groups; provided that when Y represents -E-D, and E represents a bond, then D does not represent  wherein R1′ represents hydrogen, C1-6alkyl, C2-4alkenyl, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl, cyanoC1-4alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, C1-6alkyl substituted with —NR4R5, C1-6alkyl substituted with —C(═O)—NR4R5, —S(═O)2—C1-6alkyl, —S(═O)2—haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2—haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2—haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R6, C1-6alkyl substituted with R6, C1-6alkyl substituted with —C(═O)—R6, hydroxyC1-6alkyl substituted with R6, C1-6alkyl substituted with —Si(CH3)3, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; and each R1a is independently selected from hydrogen, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkyl substituted with amino or mono- or di(C1-4alkyl)amino or —NH(C3-8cycloalkyl), cyanoC1-4alkyl, C1-4alkoxyC1-4alkyl, and C1-4alkyl substituted with one or more fluoro atoms; R1 represents hydrogen, halo, cyano, C1-6alkyl, C1-6alkoxy, —C(═O)—O—C1-6alkyl, C2-4alkenyl, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl, cyanoC1-4alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, —NR4R5, C1-6alkyl substituted with —O—C(═O)—C1-6alkyl, C1-6alkyl substituted with —NR4R5, —C(═O)—NR4R5, —C(═O)—C1-6alkyl-NR4R5, C1-6alkyl substituted with —C(═O)—NR4R5, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6 alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R6, C1-6alkyl substituted with R6, —C(═O)—R6, C1-6alkyl substituted with —C(═O)—R6, hydroxyC1-6alkyl substituted with R6, C1-6alkyl substituted with —Si(CH3)3, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; R3a represents —NR10R11, hydroxyl, C1-6alkoxy, hydroxyC1-6alkoxy, C1-6alkoxy substituted with —NR10R11, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC2-6alkenyl, hydroxyC2-6alkynyl, hydroxyhaloC1-6alkyl, cyanoC1-6alkyl, C1-6alkyl substituted with carboxyl, C1-6alkyl substituted with —C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—O—C1-6alkyl, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-O—C(═O)—, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-C(═O)—, C1-6alkyl substituted with —O—C(═O)—C1-6alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups or with —O—C(═O)—C1-6alkyl, C2-6alkenyl substituted with C1-6alkoxy, C2-6alkynyl substituted with C1-6alkoxy, C1-6alkyl substituted with R9 and optionally substituted with —O—C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—R9, C1-6alkyl substituted with hydroxyl and R9, C2-6alkenyl substituted with R9, C2-6alkynyl substituted with R9, C1-6alkyl substituted with —NR10R11, C2-6alkenyl substituted with —NR10R11, C2-6alkynyl substituted with —NR10R11, C1-6alkyl substituted with hydroxyl and —NR10R11, C1-6alkyl substituted with one or two halogens and —NR10R11, —C1-6alkyl-C(R12)═N—O—R12, C1-6alkyl substituted with —C(═O)—NR10R11, C1-6alkyl substituted with —O—C(═O)—NR10R11, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NR12—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R13, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; R3b represents hydrogen or hydroxyl; provided that if R3a represents —NR10R11, then R3b represents hydrogen; or R3a and R3b are taken together to form ═O, to form ═NR10, to form cyclopropyl together with the carbon atom to which they are attached, to form ═CH—C0-4alkyl substituted with R3c, or to form  wherein ring A is a monocyclic 5 to 7 membered saturated heterocycle containing one heteroatom selected from N, O and S, said heteroatom not being positioned in alpha position of the double bond, wherein ring A is optionally being substituted with cyano, C1-4alkyl, hydroxyC1-4alkyl, H2N—C1-4alkyl, (C1-4alkyl)NH—C1-4alkyl, (C1-4alkyl)2N—C1-4alkyl, haloC1-4alkyl)NH—C1-4alkyl, C1-4alkoxyC1-4alkyl, —C(═O)—NH2, —C(═O)—NH(C1-4alkyl), —C(═O)—N(C1-4alkyl)2; R3c represents hydrogen, hydroxyl, C1-6alkoxy, R9, —NR10R11, cyano, —C(═O)—C1-6alkyl or —CH(OH)—C1-6alkyl; R3 represents hydroxyl, C1-6alkoxy, hydroxyC1-6alkoxy, C1-6alkoxy substituted with —NR10R11, C1-6alkyl, C2-6alkenyl, C2-6alkynyl, haloC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC1-6alkyl optionally substituted with —O—C(═O)—C1-6alkyl, hydroxyC2-6alkenyl, hydroxyC2-6alkynyl, hydroxyhaloC1-6alkyl, cyanoC1-6alkyl, C1-6alkyl substituted with carboxyl, C1-6alkyl substituted with —C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—O—C1-6alkyl, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-O—C(═O)—, C1-6alkyl substituted with C1-6alkoxyC1-6alkyl-C(═O)—, C1-6alkyl substituted with —O—C(═O)—C1-6alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups or with —O—C(═O)—C1-6alkyl, C2-6alkenyl substituted with C1-6alkoxy, C2-6alkynyl substituted with C1-6alkoxy, C1-6alkyl substituted with R9 and optionally substituted with —O—C(═O)—C1-6alkyl, C1-6alkyl substituted with —C(═O)—R9, C1-6alkyl substituted with hydroxyl and R9, C2-6alkenyl substituted with R9, C2-6alkynyl substituted with R9, C1-6alkyl substituted with —NR10R11, C2-6alkenyl substituted with —NR10R11, C2-6alkynyl substituted with —NR10R11, C1-6alkyl substituted with hydroxyl and —NR10R11, C1-6alkyl substituted with one or two halogens and —NR10R11, —C1-6alkyl-C(R12)═N—O—R12, C1-6alkyl substituted with —C(═O)—NR10R11, C1-6alkyl substituted with —O—C(═O)—NR10R11, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(O)2—NR14R15, C1-6alkyl substituted with —NR12—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NR12—S(═O)2—NR14R15, R13, C1-6alkyl substituted with —P(═O)(OH)2 or C1-6alkyl substituted with —P(═O)(OC1-6alkyl)2; R4 and R5 each independently represent hydrogen, C1-6alkyl, C1-6alkyl substituted with —NR14R15, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, —C(═O)—NR14R15, —C(═O)—O—C1-6alkyl, —C(═O)—R13, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2—NR14R15, R13 or C1-6alkyl substituted with R13; R6 represents C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, 4 to 7-membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S; said C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, 4 to 7-membered monocyclic heterocyclyl, optionally and each independently being substituted by 1, 2, 3, 4 or 5 substituents, each substituent independently being selected from cyano, C1-6alkyl, cyanoC1-6alkyl, hydroxyl, carboxyl, hydroxyC1-6alkyl, halogen, haloC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxy, C1-6alkoxyC1-6alkyl, C1-6alkyl—O—C(═O)—, —NR14R15, —C(═O)—NR14R15, C1-6alkyl substituted with —NR14R15, C1-6alkyl substituted with —C(═O)—NR14R15, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl or C1-6alkyl substituted with —NH—S(═O)2—NR14R15; R7 and R8 each independently represent hydrogen, C1-6alkyl, hydroxyC1-6alkyl, haloC1-6alkyl, hydroxyhaloC1-6alkyl or C1-6alkoxyC1-6alkyl; R9 represents C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, naphthyl, or 3 to 12 membered monocyclic or bicyclic heterocyclyl containing at least one heteroatom selected from N, O and S, said C3-8cycloalkyl, C3-8cycloalkenyl, phenyl, naphthyl, or 3 to 12 membered monocyclic or bicyclic heterocyclyl each optionally and each independently being substituted with 1, 2, 3, 4 or 5 substituents, each substituent independently being selected from ═O, C1-4alkyl, hydroxyl, carboxyl, hydroxyC1-4alkyl, cyano, cyanoC1-4alkyl, C1-4-O—C(═O)—, C1-4alkyl substituted with C1-4alkyl-O—C(═O)—, C1-4alkoxyC1-4alkyl wherein each C1-4alkyl may optionally be substituted with one or two hydroxyl groups, halogen, haloC1-4alkyl, hydroxyhaloC1-4alkyl, —NR14R15, —C(═O)—NR14R15, C1-4alkyl substituted with —NR14R15, C1-4alkyl substituted with —C(═O)—NR14R15, C1-4alkoxy, —S(═O)2—C1-4alkyl, —S(═O)2-haloC1-4alkyl, —S(═O)2—NR14R15, C1-4alkyl substituted with —S(═O)2—NR14R15, C1-4alkyl substituted with —NH—S(═O)2—C1-4alkyl, C1-4alkyl substituted with —NH—S(═O)2-haloC1-4alkyl, C1-4alkyl substituted with —NH—S(═O)2—NR14R15, R13, —C(═O)—R13, C1-4alkyl substituted with R13, phenyl optionally substituted with R16, phenylC1-6alkyl wherein the phenyl is optionally substituted with R16, a 5 or 6-membered aromatic monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S wherein said heterocyclyl is optionally substituted with R16; or when two of the substituents of R9 are attached to the same atom, they may be taken together to form a 4 to 7-membered saturated monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S; R10 and R11 each independently represent hydrogen, carboxyl, C1-6alkyl, cyanoC1-6alkyl, C1-6alkyl substituted with —NR14R15, C1-6alkyl substituted with —C(═O)—NR14R15, haloC1-6alkyl, hydroxyC1-6alkyl, hydroxyhaloC1-6alkyl, C1-6alkoxy, C1-6alkoxyC1-6alkyl wherein each C1-6alkyl may optionally be substituted with one or two hydroxyl groups, R6, C1-6alkyl substituted with R6, —C(═O)—R6, —C(═O)—C1-6alkyl, —C(═O)-hydroxyC1-6alkyl, —C(═O)-haloC1-6alkyl, —C(═O)-hydroxyhaloC1-6alkyl, C1-6alkyl substituted with —Si(CH3)3, —S(═O)2—C1-6alkyl, —S(═O)2-haloC1-6alkyl, —S(═O)2—NR14R15, C1-6alkyl substituted with —S(═O)2—C1-6alkyl, C1-6alkyl substituted with —S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with —S(═O)2—NR14R15, C1-6alkyl substituted with —NH—S(═O)2—C1-6alkyl, C1-6alkyl substituted with —NH—S(═O)2-haloC1-6alkyl, C1-6alkyl substituted with carboxyl, or C1-6alkyl substituted with —NH—S(═O)2—NR14R15; R12 represents hydrogen or C1-4alkyl optionally substituted with C1-4alkoxy; R13 represents C3-8cycloalkyl or a saturated 4 to 6-membered monocyclic heterocyclyl containing at least one heteroatom selected from N, O and S, wherein said C3-8cycloalkyl or monocyclic heterocyclyl is optionally substituted with 1, 2 or 3 substituents each independently selected from halogen, hydroxyl, C1-6alkyl, haloC1-6alkyl, ═O, cyano, —C(═O)—C1-6alkyl, C1-6alkoxy, or —NR14R15; R14 and R15 each independently represent hydrogen, or haloC1-4alkyl, or C1-4alkyl optionally substituted with a substituent selected from hydroxyl, C1-4alkoxy, amino or mono- or di(C1-4alkyl)amino; R16 represents hydroxyl, halogen, cyano, C1-4alkyl, C1-4alkoxy, —NR14R15 or —C(═O)NR14R15; R18 represents hydrogen, C1-6 alkyl, C3-8 cycloalkyl, C1-4alkyl substituted with C3-8 cycloalkyl; R19 represents hydrogen; C1-6 alkyl; C3-8 cycloalkyl; C1-6alkyl substituted with —O—R20; —(CH2)r—CN; —(CH2)r—CONR20R21; —(CH2)r1—NR20R21; —(CH2)r1—NR20COR21; —(CH2)r1—NR20—(CH2)s—SO2—R21; —(CH2)r1—NH—SO2—NR20R21—(CH2)r1—NR20CO2R21; —(CH2)r—SO2NR20R21; phenyl optionally substituted with 1, 2, 3, 4 or 5 substituents each independently selected from halogen, C1-4alkyl, C1-4alkyloxy, cyano and amino; a 5- or 6-membered aromatic monocyclic heterocycle containing at least one heteroatom selected from N, O and S, said heterocycle being optionally substituted with 1, 2, 3 or 4 substituents each independently selected from halogen, C1-4alkyl, C1-4alkyloxy, cyano or amino; wherein said C1-6 alkyl and C3-8 cycloalkyl, may be optionally substituted by one or more R20 groups R20 and R21 independently represent hydrogen, C1-6 alkyl, hydroxyC1-6alkyl, —(CH2)n—O—C1-6alkyl, or when attached to a nitrogen atom R20 and R21 can be taken together to form with the nitrogen atom to which they are attached a monocyclic saturated 4, 5 or 6-membered ring which optionally contains a further heteroatom selected from O, S and N; R22 and R23 independently represent hydrogen, C1-6 alkyl, or hydroxyC1-6alkyl; m independently represents an integer equal to 0, 1 or 2; n independently represents an integer equal to 0, 1, 2, 3 or 4; s independently represents an integer equal to 0, 1, 2, 3 or 4; r independently represent an integer equal to 1, 2, 3, or 4; r1 independently represent an integer equal to 2, 3 or 4; provided that when R3a and R3b are taken together to form ═O, n represents 0, Y represents -E-D, and E represents a bond, then D does not represent unsubstituted phenyl; or an N-oxide thereof, a pharmaceutically acceptable salt thereof or a solvate thereof.
地址 Cambridge GB